Year |
Citation |
Score |
2020 |
Mohamed E, Sierra RA, Trillo-Tinoco J, Cao Y, Innamarato P, Payne KK, de Mingo Pulido A, Mandula J, Zhang S, Thevenot P, Biswas S, Abdalla SK, Costich TL, Hänggi K, Anadon CM, et al. The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling. Immunity. 52: 668-682.e7. PMID 32294407 DOI: 10.1016/J.Immuni.2020.03.004 |
0.344 |
|
2020 |
Truong T, Ramalingam V, Morris T, Gimenez J, Gulotta P, Thevenot P, Nunez K, Gilbert P, Marsala A, Tramel R, Galliano G, Cohen A, Kay D, Sandow T. 3:54 PM Abstract No. 233 Immune status correlates with locoregional treatment response, new tumor development, and tumor necrosis in patients with hepatocellular carcinoma Journal of Vascular and Interventional Radiology. 31. DOI: 10.1016/J.Jvir.2019.12.276 |
0.304 |
|
2019 |
Sandow T, Nunez K, Gimenez J, Ramalingam V, Gulotta P, Robertson S, Gilbert P, Marsala A, DeVun D, Kay D, Cohen A, Thevenot P. 03:45 PM Abstract No. 213 Synthetic liver function and absolute lymphocyte count are associated with tumor response to locoregional therapy as well as immunosuppressive cell populations in transplant waitlist patients with hepatocellular carcinoma: single-center, prospective, observational trial Journal of Vascular and Interventional Radiology. 30. DOI: 10.1016/J.Jvir.2018.12.270 |
0.33 |
|
2019 |
Nunez KG, Sandow T, Robertson S, Cohen AJ, Thevenot PT. Liver functional reserve and pre-treatment immune tolerance in waitlist treatment naïve HCC patients is associated with poor tumor response to locoregional therapy Hpb. 21. DOI: 10.1016/J.Hpb.2019.03.188 |
0.301 |
|
2017 |
Sandow TA, Arndt SE, Albar AA, DeVun DA, Kirsch DS, Gimenez JM, Bohorquez HE, Gilbert PJ, Thevenot PT, Nunez KG, Galliano GA, Cohen AJ, Kay D, Gulotta PM. Assessment of Response to Transcatheter Arterial Chemoembolization with Doxorubicin-eluting Microspheres: Tumor Biology and Hepatocellular Carcinoma Recurrence in a 5-year Transplant Cohort. Radiology. 170731. PMID 29206595 DOI: 10.1148/Radiol.2017170731 |
0.327 |
|
2016 |
Raber PL, Sierra RA, Thevenot PT, Shuzhong Z, Wyczechowska DD, Kumai T, Celis E, Rodriguez PC. T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapy. Oncotarget. PMID 27007050 DOI: 10.18632/Oncotarget.8197 |
0.343 |
|
2015 |
Fletcher M, Ramirez ME, Sierra RA, Raber P, Thevenot P, Al-Khami AA, Sanchez-Pino D, Hernandez C, Wyczechowska DD, Ochoa AC, Rodriguez PC. l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells. Cancer Research. 75: 275-83. PMID 25406192 DOI: 10.1158/0008-5472.Can-14-1491 |
0.349 |
|
2015 |
Raber P, Thevenot P, Sierra R, Rodriguez PC. Antigen-specific T cells conditioned with MDSC display a surprising increased anti-tumor activity after adoptive T cell-based immunotherapy Journal For Immunotherapy of Cancer. 3: P413. DOI: 10.1186/2051-1426-3-S2-P413 |
0.34 |
|
2014 |
Thevenot PT, Sierra RA, Raber PL, Al-Khami AA, Trillo-Tinoco J, Zarreii P, Ochoa AC, Cui Y, Del Valle L, Rodriguez PC. The stress-response sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors. Immunity. 41: 389-401. PMID 25238096 DOI: 10.1016/J.Immuni.2014.08.015 |
0.343 |
|
2014 |
Sierra RA, Thevenot P, Raber PL, Cui Y, Parsons C, Ochoa AC, Trillo-Tinoco J, Del Valle L, Rodriguez PC. Rescue of notch-1 signaling in antigen-specific CD8+ T cells overcomes tumor-induced T-cell suppression and enhances immunotherapy in cancer. Cancer Immunology Research. 2: 800-11. PMID 24830414 DOI: 10.1158/2326-6066.Cir-14-0021 |
0.333 |
|
2014 |
Raber PL, Thevenot P, Sierra R, Wyczechowska D, Halle D, Ramirez ME, Ochoa AC, Fletcher M, Velasco C, Wilk A, Reiss K, Rodriguez PC. Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways. International Journal of Cancer. Journal International Du Cancer. 134: 2853-64. PMID 24259296 DOI: 10.1002/Ijc.28622 |
0.335 |
|
2013 |
Raber PL, Thevenot P, Sierra R, Wyczechowska D, Ramirez ME, Ochoa A, Velasco C, Rodriguez PC. Independent mechanisms of T cell-suppression by subpopulations of myeloid-derived suppressor cells (MDSC) in tumor-bearing hosts Journal For Immunotherapy of Cancer. 1: P193. DOI: 10.1186/2051-1426-1-S1-P193 |
0.363 |
|
2011 |
Thevenot PT, Baker DW, Weng H, Sun MW, Tang L. The pivotal role of fibrocytes and mast cells in mediating fibrotic reactions to biomaterials. Biomaterials. 32: 8394-403. PMID 21864899 DOI: 10.1016/J.Biomaterials.2011.07.084 |
0.536 |
|
2011 |
Wang P, Thevenot P, Saravia J, Ahlert T, Cormier SA. Radical-containing particles activate dendritic cells and enhance Th17 inflammation in a mouse model of asthma. American Journal of Respiratory Cell and Molecular Biology. 45: 977-83. PMID 21493781 DOI: 10.1165/Rcmb.2011-0001Oc |
0.302 |
|
2010 |
Tran RT, Thevenot P, Gyawali D, Chiao JC, Tang L, Yang J. Synthesis and characterization of a biodegradable elastomer featuring a dual crosslinking mechanism. Soft Matter. 6: 2449-2461. PMID 22162975 DOI: 10.1039/C001605E |
0.522 |
|
2010 |
Tran RT, Thevenot P, Zhang Y, Gyawali D, Tang L, Yang J. Scaffold Sheet Design Strategy for Soft Tissue Engineering. Nature Materials. 3: 1375-1389. PMID 21113339 DOI: 10.3390/Ma3021375 |
0.543 |
|
2010 |
Sohaebuddin SK, Thevenot PT, Baker D, Eaton JW, Tang L. Nanomaterial cytotoxicity is composition, size, and cell type dependent. Particle and Fibre Toxicology. 7: 22. PMID 20727197 DOI: 10.1186/1743-8977-7-22 |
0.523 |
|
2010 |
Thevenot PT, Nair AM, Shen J, Lotfi P, Ko CY, Tang L. The effect of incorporation of SDF-1alpha into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials. 31: 3997-4008. PMID 20185171 DOI: 10.1016/J.Biomaterials.2010.01.144 |
0.698 |
|
2010 |
Nair A, Thevenot P, Dey J, Shen J, Sun MW, Yang J, Tang L. Novel polymeric scaffolds using protein microbubbles as porogen and growth factor carriers. Tissue Engineering. Part C, Methods. 16: 23-32. PMID 19327002 DOI: 10.1089/Ten.Tec.2009.0094 |
0.615 |
|
2008 |
Thevenot P, Sohaebuddin S, Poudyal N, Liu JP, Tang L. Magnetic Nanoparticles to Enhance Cell Seeding and Distribution in Tissue Engineering Scaffolds. Proceedings of the ... Ieee Conference On Nanotechnology / Co-Sponsored by Ieee Robotics and Automation Society (Ras) ... [Et Al.]. Ieee Conference On Nanotechnology. 2008: 646-649. PMID 22348179 DOI: 10.1109/NANO.2008.196 |
0.478 |
|
2008 |
Nair A, Shen J, Thevenot P, Cai T, Hu Z, Tang L. Novel Quantum Dots for Enhanced Tumor Imaging. Proceedings of the ... Ieee Conference On Nanotechnology / Co-Sponsored by Ieee Robotics and Automation Society (Ras) ... [Et Al.]. Ieee Conference On Nanotechnology. 8: 650-653. PMID 22267976 DOI: 10.1109/NANO.2008.197 |
0.597 |
|
2008 |
Nair A, Shen J, Thevenot P, Zou L, Cai T, Hu Z, Tang L. Enhanced intratumoral uptake of quantum dots concealed within hydrogel nanoparticles. Nanotechnology. 19: 485102. PMID 21836292 DOI: 10.1088/0957-4484/19/48/485102 |
0.615 |
|
2008 |
Nair A, Thevenot P, Hu W, Tang L. NANOTECHNOLOGY IN THE TREATMENT AND DETECTION OF INTRAOCULAR CANCERS. Journal of Biomedical Nanotechnology. 4: 410-418. PMID 20668648 DOI: 10.1166/Jbn.2008.004 |
0.599 |
|
2008 |
Thevenot P, Nair A, Dey J, Yang J, Tang L. Method to analyze three-dimensional cell distribution and infiltration in degradable scaffolds. Tissue Engineering. Part C, Methods. 14: 319-31. PMID 19055358 DOI: 10.1089/Ten.Tec.2008.0221 |
0.636 |
|
2008 |
Dey J, Xu H, Shen J, Thevenot P, Gondi SR, Nguyen KT, Sumerlin BS, Tang L, Yang J. Development of biodegradable crosslinked urethane-doped polyester elastomers. Biomaterials. 29: 4637-49. PMID 18801566 DOI: 10.1016/J.Biomaterials.2008.08.020 |
0.496 |
|
2008 |
Thevenot P, Cho J, Wavhal D, Timmons RB, Tang L. Surface chemistry influences cancer killing effect of TiO2 nanoparticles. Nanomedicine : Nanotechnology, Biology, and Medicine. 4: 226-36. PMID 18502186 DOI: 10.1016/J.Nano.2008.04.001 |
0.509 |
|
2008 |
Thevenot P, Hu W, Tang L. Surface chemistry influences implant biocompatibility. Current Topics in Medicinal Chemistry. 8: 270-80. PMID 18393890 DOI: 10.2174/156802608783790901 |
0.501 |
|
Show low-probability matches. |